Henry C. Nguyen

Henry C. Nguyen

Auto-generated profile, based on publicly available information

Henry C. Nguyen

Department of Biochemistry and Biophysics, University of California, San Francisco, CA, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2020 in Science
Verified
Journal Article
Open access
PDF file
DGDavid E. Gordon
David E. Gordon
JHJoseph Hiatt
Joseph Hiatt
MBMehdi Bouhaddou
Mehdi Bouhaddou
VRVeronica V. Rezelj
Veronica V. Rezelj
SUSvenja Ulferts
Svenja Ulferts
HLHarris A. Lewin
Harris A. Lewin
How lethal coronaviruses engage hosts: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is closely related to the deadly coronaviruses SARS-CoV-1 and Middle East respiratory syndrome coronavirus (MERS-CoV). Considerable efforts are focused on developing treatments, and therapies that work across coronaviruses would be particularly valuable. Shedding light on the host factors hijacked by the viruses, Gordon et al. mapped the interactions between viral and human proteins for SARS-CoV-2, SARS-CoV-1, and MERS-CoV; analyzed the localization of viral proteins in human cells; and used genetic screening to identify host factors that either enhance or inhibit viral infection. For a subset of the interactions essential for the virus life cycle, the authors determined the cryo–electron microscopy structures and mined patient data to understand how targeting host factors may be relevant to clinical outcomes. Science , this issue p. eabe9403

1 January 2015 in Cell Reports
Verified
Journal Article
Open access
AAAnas M. Alazami
Anas M. Alazami
NPNisha Patel
Nisha Patel
HSHanan E. Shamseldin
Hanan E. Shamseldin
SAShamsa Anazi
Shamsa Anazi
MAMohammed S. Al-Dosari
Mohammed S. Al-Dosari
FAFowzan S. Alkuraya
Fowzan S. Alkuraya
Our knowledge of disease genes in neurological disorders is incomplete. With the aim of closing this gap, we performed whole-exome sequencing on 143 multiplex consanguineous families in whom known disease genes had been excluded by autozygosity mapping and candidate gene analysis. This prescreening step led to the identification of 69 recessive genes not previously associated with disease, of which 33 are here described (SPDL1, TUBA3E, INO80, NID1, TSEN15, DMBX1, CLHC1, C12orf4, WDR93, ST7, MATN4, SEC24D, PCDHB4, PTPN23, TAF6, TBCK, FAM177A1, KIAA1109, MTSS1L, XIRP1, KCTD3, CHAF1B, ARV1, ISCA2, PTRH2, GEMIN4, MYOCD, PDPR, DPH1, NUP107, TMEM92, EPB41L4A, and FAM120AOS). We also encountered instances in which the phenotype departed significantly from the established clinical presentation of a known disease gene. Overall, a likely causal mutation was identified in >73% of our cases. This study contributes to the global effort toward a full compendium of disease genes affecting brain function.

18 December 2020 in Science
Verified
Journal Article
Open access
PDF file
MSMichael Schoof
Michael Schoof
BFBryan Faust
Bryan Faust
RSReuben A. Saunders
Reuben A. Saunders
SSSmriti Sangwan
Smriti Sangwan
VRVeronica Rezelj
Veronica Rezelj
AMAashish Manglik
Aashish Manglik
Nanobodies that neutralize: Monoclonal antibodies that bind to the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) show therapeutic promise but must be produced in mammalian cells and need to be delivered intravenously. By contrast, single-domain antibodies called nanobodies can be produced in bacteria or yeast, and their stability may enable aerosol delivery. Two papers now report nanobodies that bind tightly to spike and efficiently neutralize SARS-CoV-2 in cells. Schoof et al. screened a yeast surface display of synthetic nanobodies and Xiang et al. screened anti-spike nanobodies produced by a llama. Both groups identified highly potent nanobodies that lock the spike protein in an inactive conformation. Multivalent constructs of selected nanobodies achieved even more potent neutralization. Science , this issue p. 1473 , p. 1479

30 March 2018 in Science
Verified
Journal Article
Closed access
PDF file
JTJordan C. Tsai
Jordan C. Tsai
LMLakshmi E. Miller-Vedam
Lakshmi E. Miller-Vedam
AAAditya A. Anand
Aditya A. Anand
PJPriyadarshini Jaishankar
Priyadarshini Jaishankar
HNHenry C. Nguyen
Henry C. Nguyen
PWPeter Walter
Peter Walter
ISRIB mechanism of action: In rodents, a druglike small molecule named ISRIB enhances cognition and reverses cognitive deficits after traumatic brain injury. ISRIB activates a protein complex called eIF2B that is required for the synthesis of new proteins. Tsai et al. report the visualization of eIF2B bound to ISRIB at near-atomic resolution by cryo–electron microscopy. Biochemical studies revealed that ISRIB is a “molecular staple” that promotes assembly of the fully active form of eIF2B. Zyryanova et al. report similar structures together with information on the binding of ISRIB analogs and their effects on protein translation. Science , this issue p. eaaq0939 , p. 1533

1 November 2014 in Cell Host & Microbe
Verified
Journal Article
Closed access
JFJennifer L. Fribourgh
Jennifer L. Fribourgh
HNHenry C. Nguyen
Henry C. Nguyen
KMKenneth Matreyek
Kenneth Matreyek
FAFrances Joan D. Alvarez
Frances Joan D. Alvarez
BSBrady J. Summers
Brady J. Summers
YXYong Xiong
Yong Xiong

3 May 2019 in Science
Verified
Journal Article
Closed access
PDF file
LKLillian R. Kenner
Lillian R. Kenner
AAAditya A. Anand
Aditya A. Anand
HNHenry C. Nguyen
Henry C. Nguyen
AMAlexander Myasnikov
Alexander Myasnikov
CKCarolin J. Klose
Carolin J. Klose
AFAdam Frost
Adam Frost
Integrated stress response on the brain: During translation, regulation of protein synthesis by phosphorylation of eukaryotic translation initiation factor 2 (eIF2) is a common consequence of diverse stress stimuli, which leads to reprogramming of gene expression. This process, known as the integrated stress response, is one of the most fundamental mechanisms of translational control conserved throughout eukaryotes. It is also a promising therapeutic target in neurodegenerative diseases and traumatic brain injury. Kashiwagi et al. report the cryo–electron microscopy and crystal structures and Kenner et al. report the cryo–electron microscopy structure of the guanine nucleotide exchange factor eIF2B in complex with eIF2 or phosphorylated eIF2. The structures of the eIF2•eIF2B complex reveal that the single phosphorylation modification on eIF2 changes how eIF2 binds to eIF2B and locks this enzyme into an inhibited complex. Science , this issue p. 495 , p. 491